Toru Sakuragi

Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer

Kentaro Iwanaga, Naoko Sueoka, Akemi Sato et al. · Cancer Letters · 2003 · 54 citations

Oncogenic Agent, Medicine, Pathology +10

Predictive factors for survival in surgically resected clinical IA peripheral adenocarcinoma of the lung

Yukinori Sakao, Takahiko Nakazono, Toru Sakuragi et al. · The Annals of Thoracic Surgery · 2004 · 44 citations

Surgical Oncology, Predictive Factors, Medicine +8

Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells

Kazutoshi Komiya, Naoko Sueoka‐Aragane, Akemi Sato et al. · Journal of Cancer Research and Clinical Oncology · 2009 · 37 citations · Full text

Lung Cancers, Oncogenic Agent, Medicine +11

Clinicopathological analysis of prognostic factors in clinical IA peripheral adenocarcinoma of the lung

Yukinori Sakao, Toru Sakuragi, Masafumi Natsuaki et al. · The Annals of Thoracic Surgery · 2003 · 36 citations

Prognostic Factors, Advanced Lung Disease, Medicine +8

Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer

Kazutoshi Komiya, Naoko Sueoka‐Aragane, Akemi Sato et al. · Lung Cancer · 2009 · 35 citations

Tumor Biology, Oncology, Favorable Prognostic Marker +11